CA2100352A1 - Nouvelle sous-unite .beta. d'integrine et applications - Google Patents
Nouvelle sous-unite .beta. d'integrine et applicationsInfo
- Publication number
- CA2100352A1 CA2100352A1 CA002100352A CA2100352A CA2100352A1 CA 2100352 A1 CA2100352 A1 CA 2100352A1 CA 002100352 A CA002100352 A CA 002100352A CA 2100352 A CA2100352 A CA 2100352A CA 2100352 A1 CA2100352 A1 CA 2100352A1
- Authority
- CA
- Canada
- Prior art keywords
- integrin
- beta
- subunit
- ligand
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1991/000236 WO1992012236A1 (fr) | 1991-01-11 | 1991-01-11 | NOUVELLE SOUS-UNITE β D'INTEGRINE ET SES PROCEDES D'UTILISATION |
| CA002100352A CA2100352A1 (fr) | 1991-01-11 | 1991-01-11 | Nouvelle sous-unite .beta. d'integrine et applications |
| JP3504047A JPH07500721A (ja) | 1991-01-11 | 1991-01-11 | 新規なインテグリンβサブユニット及びその使用 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1991/000236 WO1992012236A1 (fr) | 1991-01-11 | 1991-01-11 | NOUVELLE SOUS-UNITE β D'INTEGRINE ET SES PROCEDES D'UTILISATION |
| CA002100352A CA2100352A1 (fr) | 1991-01-11 | 1991-01-11 | Nouvelle sous-unite .beta. d'integrine et applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2100352A1 true CA2100352A1 (fr) | 1992-07-12 |
Family
ID=25676369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002100352A Abandoned CA2100352A1 (fr) | 1991-01-11 | 1991-01-11 | Nouvelle sous-unite .beta. d'integrine et applications |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2100352A1 (fr) |
| WO (1) | WO1992012236A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE385503T1 (de) * | 1999-06-28 | 2008-02-15 | Inter K Pty Ltd | Verfahren zur modulierung von integrin- vermittelter zellaktivitaet und hierfuer geeignete reagenzien |
| AUPR230500A0 (en) | 2000-12-22 | 2001-01-25 | University Of Newcastle Research Associates Limited, The | A method of modulating map kinase mediated cellular activity and agents useful in same |
| AU2002335930B2 (en) | 2001-03-09 | 2005-07-28 | Morphosys Ag | Serum albumin binding moieties |
| CA2481922A1 (fr) * | 2002-04-12 | 2003-10-23 | Raven Biotechnologies, Inc. | Anticorps se liant a l'integrine alpha-v-beta-6 et leurs methodes d'utilisation |
| EP2305836A1 (fr) * | 2002-08-20 | 2011-04-06 | Millennium Pharmaceuticals, Inc. | Compositions, kits et procédés d'identification, évaluation, prévention et thérapie du cancer du col de l'utérus |
| EP2418219B1 (fr) | 2003-10-17 | 2018-06-27 | InterK Peptide Therapeutics Limited | Procédés et agents de traitement du cancer |
-
1991
- 1991-01-11 CA CA002100352A patent/CA2100352A1/fr not_active Abandoned
- 1991-01-11 WO PCT/US1991/000236 patent/WO1992012236A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992012236A1 (fr) | 1992-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090253146A1 (en) | Methods of expressing integrin beta6 subunits | |
| Takada et al. | Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. | |
| US5459061A (en) | Hybridomas producing monoclonal antibodies which specifically bind to continuous epitope on the human EGF receptor and compete with EGF for binding to the EGF receptor | |
| Song et al. | H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. | |
| Wong et al. | Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62 | |
| EP1464706A2 (fr) | HEK5, HEK7, HEK8 et HEK11: des récepteurs protéine tyrosine kinase d'analogues de l'EPH | |
| FI100601B (fi) | Menetelmä liukoisen intrasellulaarisen adheesiomolekyyli-1:n (sICAM-1) ja sen vasta-aineen valmistamiseksi sekä sICAM-1:tä koodaava DNA, sit ä sisältävä solu ja vasta-ainetta tuottava hybridooma | |
| AU3353293A (en) | Tie, a novel endothelial cell receptor tyrosine kinase | |
| CA2008368C (fr) | Molecule soluble apparentee a l'icam-i mais distincte | |
| WO1992019647A1 (fr) | Polypeptides definissant le domaine cytoplasmique des sous-unitesde l'integrine alpha, anticorps et procedes d'utilisation correspondants | |
| US7297493B2 (en) | Fibroblast growth factor receptor activating gene 1 and related compositions and methods | |
| Khan et al. | Antibodies to the human γ2 subunit of the γ‐aminobutyric acidA/benzodiazepine receptor | |
| Bahou et al. | The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: molecular and functional characterization | |
| CA2100352A1 (fr) | Nouvelle sous-unite .beta. d'integrine et applications | |
| EP0580672B1 (fr) | ANTIGENE SYNTHETIQUE DE PEPTIDE CDw52(CAMPATH-1) | |
| US5525487A (en) | DNA encoding I-CAM related protein | |
| Prince et al. | Characterization of a partial cDNA clone for the NILE glycoprotein and identification of the encoded polypeptide domain | |
| AU602487B2 (en) | Molecular cloning of cDNA for human factor VIIIR (von Willebrand factor) | |
| CA2101632A1 (fr) | Recepteurs pour facteur de croissance d'origine plaquettaire | |
| US5504192A (en) | Human insulin receptor endocytic code binding protein | |
| AU6299390A (en) | Fibulin | |
| Wennogle et al. | Stabilization of C5a receptor–G‐protein interactions through ligand binding | |
| CA2008735C (fr) | Sequences receptrice du facteur de croissance epidermique humain (fce) et anticorps monoclonaux competitifs du fce | |
| Théveniau et al. | Antipeptide antibodies to the 141-1141-1141-1receptor confirm the extracellular orientation of the amino-terminus and the putative first extracellular loop | |
| US20060216287A1 (en) | EPH-like receptor protein tyrosine kinases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |